Á lódáil...
Safinamide: an add-on treatment for managing Parkinson’s disease
Heterogeneous expression of neurotransmitter deficits results from onset and progression of Parkinson’s disease. Intervals, characterized by reappearance of motor and associated certain nonmotor symptoms, determine the end of good tolerability and efficacy of oral levodopa therapy. These “OFF” state...
Na minha lista:
| Foilsithe in: | Clin Pharmacol |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896660/ https://ncbi.nlm.nih.gov/pubmed/29670409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S137740 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|